CE Form 4: Director Scott McDougald acquires 2,000 shares
Rhea-AI Filing Summary
Celanese Corporation (CE) director Scott McDougald reported a non-derivative purchase of 2,000 shares on 08/14/2025 at a price of $40.8935 per share, increasing his direct beneficial ownership to 20,376 shares. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions or additional remarks were reported.
Positive
- Director purchase disclosed: Report shows a purchase of 2,000 shares on 08/14/2025 at $40.8935.
- Clear ownership update: Direct beneficial ownership after the trade is stated as 20,376 shares.
- Proper filing execution: Form 4 was signed (by attorney-in-fact) and includes required transaction details.
Negative
- None.
Insights
TL;DR: Director executed a straightforward open-market purchase of 2,000 shares, modestly increasing direct holdings.
The filing documents a single non-derivative transaction: a purchase (code P) of 2,000 shares at $40.8935 on 08/14/2025, bringing direct ownership to 20,376 shares. The disclosure was executed via attorney-in-fact and contains no derivative activity, amendments, or additional explanatory remarks. For investors, this is a routine Section 16 disclosure of insider activity without further material context provided in the form.
TL;DR: Routine insider buy reported by a director; filing is complete and shows no irregularities.
The Form 4 indicates the reporting person is a director and filed individually. The transaction type, number of shares, price, and resulting ownership are all specified, and the form was signed by an authorized attorney-in-fact. There are no indications of joint filings, derivative positions, or corrective amendments. This appears to be a standard compliance disclosure under Section 16.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,000 | $40.8935 | $82K |